Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76126 - 76150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sulindac	Approved Investigational	PCDH17	27253	downregulated	Sulindac results in decreased expression of PCDH17 mRNA	13q21.1	A20927
Sulindac	Approved Investigational	PCK2	5106	upregulated	Sulindac results in increased expression of PCK2 mRNA	14q11.2-q12	A20927
Sulindac	Approved Investigational	PDLIM7	9260	upregulated	Sulindac results in increased expression of PDLIM7 mRNA	5q35.3	A20927
Sulindac	Approved Investigational	PKD1	5310	upregulated	Sulindac results in increased expression of PKD1 mRNA	16p13.3	A20927
Sulindac	Approved Investigational	PLEKHF1	79156	upregulated	Sulindac results in increased expression of PLEKHF1 mRNA	19q12	A20927
Sulindac	Approved Investigational	PLXNA3	55558	upregulated	Sulindac results in increased expression of PLXNA3 mRNA	Xq28	A20927
Sulindac	Approved Investigational	PML	5371	upregulated	Sulindac results in increased expression of PML mRNA	15q24.1	A24350
Sulindac	Approved Investigational	RELA	5970	upregulated	Sulindac results in increased expression of RELA mRNA	11q13.1	A24350
Sulindac	Approved Investigational	RNASE1	6035	downregulated	Sulindac results in decreased expression of RNASE1 mRNA	14q11.2	A20927
Sulindac	Approved Investigational	RNF26	79102	downregulated	Sulindac results in decreased expression of RNF26 mRNA	11q23	A20927
Sulindac	Approved Investigational	SAT1	6303	upregulated	Sulindac results in increased expression of SAT1 mRNA	Xp22.11	A11952 A20962
Sulindac	Approved Investigational	SERPINB1	1992	upregulated	Sulindac results in increased expression of SERPINB1 mRNA	6p25.2	A24352
Sulindac	Approved Investigational	SIRT1	23411	upregulated	Sulindac results in increased expression of SIRT1 mRNA	10q21.3	A20927
Sulindac	Approved Investigational	SLC16A6	9120	upregulated	Sulindac results in increased expression of SLC16A6 mRNA	17q24.2	A20927
Sulindac	Approved Investigational	SLC30A1	7779	upregulated	Sulindac results in increased expression of SLC30A1 mRNA	1q32.3	A20927
Sulindac	Approved Investigational	SLC38A2	54407	upregulated	Sulindac results in increased expression of SLC38A2 mRNA	12q13.11	A20927
Sulindac	Approved Investigational	SLC3A2	6520	upregulated	Sulindac results in increased expression of SLC3A2 mRNA	11q12.3	A20927
Sulindac	Approved Investigational	SLC7A1	6541	upregulated	Sulindac results in increased expression of SLC7A1 mRNA	13q12.3	A20927
Sulindac	Approved Investigational	SNX21	90203	upregulated	Sulindac results in increased expression of SNX21 mRNA	20q13.12	A20927
Sulindac	Approved Investigational	SNX25	83891	upregulated	Sulindac results in increased expression of SNX25 mRNA	4q35.1	A20927
Sulindac	Approved Investigational	SQSTM1	8878	upregulated	Sulindac results in increased expression of SQSTM1 mRNA	5q35.3	A20927
Sulindac	Approved Investigational	STC2	8614	upregulated	Sulindac results in increased expression of STC2 mRNA	5q35.2	A20927
Sulindac	Approved Investigational	STXBP2	6813	upregulated	Sulindac results in increased expression of STXBP2 mRNA	19p13.2	A20927
Sulindac	Approved Investigational	SUMO3	6612	downregulated	Sulindac results in decreased expression of SUMO3 mRNA	21q22.3	A20927
Sulindac	Approved Investigational	SUN2	25777	downregulated	Sulindac results in decreased expression of SUN2 mRNA	22q13.1	A20927

Displaying entries 76126 - 76150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability